Immatics (IMTX) has had the highest return between April 25, 2015 and April 25, 2025 by a US stock in the Biotechnology Industry, returning 90,300%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immatics (IMTX) | 4/25/2015 - 4/25/2025 | 90,300% |
Azitra (AZTR) | 4/25/2015 - 4/25/2025 | 5,575% |
argenx NV ADR (ARGX) | 4/25/2015 - 4/25/2025 | 3,334.41% |
Immunoprecise Antibodies (IPA) | 4/25/2015 - 4/25/2025 | 2,207.69% |
Krystal Biotech (KRYS) | 4/25/2015 - 4/25/2025 | 1,500.57% |
Exelixis (EXEL) | 4/25/2015 - 4/25/2025 | 1,107.42% |
Vericel Corp Ord (VCEL) | 4/25/2015 - 4/25/2025 | 1,019.15% |
BeiGene (ONC) | 4/25/2015 - 4/25/2025 | 745.36% |
Ascendis Pharma A-S (ASND) | 4/25/2015 - 4/25/2025 | 706.63% |
NewAmsterdam Pharma Company NV Warrant (NAMSW) | 4/25/2015 - 4/25/2025 | 698% |
Natera (NTRA) | 4/25/2015 - 4/25/2025 | 595.88% |
Catalyst Pharmaceuticals (CPRX) | 4/25/2015 - 4/25/2025 | 527.01% |
BioNTech SE (BNTX) | 4/25/2015 - 4/25/2025 | 526.49% |
Cytokinetics (CYTK) | 4/25/2015 - 4/25/2025 | 457.66% |
Anavex Life Sciences (AVXL) | 4/25/2015 - 4/25/2025 | 440.76% |
Belite Bio Inc ADR (BLTE) | 4/25/2015 - 4/25/2025 | 365.84% |
Indivior PLC Ordinary Shares (INDV) | 4/25/2015 - 4/25/2025 | 355.14% |
Sarepta Therapeutics (SRPT) | 4/25/2015 - 4/25/2025 | 348.37% |
AquaBounty Technologies (AQB) | 4/25/2015 - 4/25/2025 | 348.13% |
Merus (MRUS) | 4/25/2015 - 4/25/2025 | 346.87% |
AbbVie (ABBV) | 4/25/2015 - 4/25/2025 | 327.51% |
Nuvalent (NUVL) | 4/25/2015 - 4/25/2025 | 305.97% |
MoonLake Immunotherapeutics (MLTX) | 4/25/2015 - 4/25/2025 | 287.99% |
Blueprint Medicines (BPMC) | 4/25/2015 - 4/25/2025 | 274.62% |
Protagonist Therapeutics (PTGX) | 4/25/2015 - 4/25/2025 | 270.75% |
